REGISTER FREE WEBINAR
UNBIASED INFORMATION ON MEDICINES: WHY IS IT NEEDED? Commercial influence is widespread in medical and pharmacy education, and has been called the ‘hidden curriculum’. Often, health professionals believe they are not influenced by pharmaceutical promotion despite research evidence to the contrary. Students often receive little training on how to critically evaluate promotional claims or information biases. The risk for patients is both costlier and poorer quality care. Heavily promoted medicines, like Avandia (rosiglitazone) and Mediator (benfluorex), are often no safer or more effective than less costly alternatives.
Wednesday, 17 October, 2018 18h30 – 20h00 (CEST) Join Health Action International (HAI) and Dr Barbara Mintzes to discuss solutions: How to recognise and respond to pharmaceutical promotion. Where to find independent information. The types of policy and institutional changes that students and consumers have fought for and achieved. Barbara Mintzes is a Senior Lecturer at the School of Pharmacy and Charles Perkins Centre, University of Sydney. She has a PhD in Epidemiology from the University of British Columbia (UBC, 2003). She works with the Therapeutics Initiative, a research group based at UBC, on systematic reviews of new drug treatments and a drug information bulletin. She is also a long-time member of the International Society of Independent Drug Bulletins and HAI. Register with the following link or by the clickable QR code: http://bit.ly/2DoaO8i